Ivermectin; authorize over-the-counter sale.
Virginia bill would allow over-the-counter ivermectin sales, removing prescription requirements and raising concerns about medical safety and off-label use without healthcare provider oversight.
Virginia bill would allow over-the-counter ivermectin sales, removing prescription requirements and raising concerns about medical safety and off-label use without healthcare provider oversight.
SB 545 would authorize the over-the-counter (OTC) sale of ivermectin in Virginia without a prescription. Currently, ivermectin is only available by prescription from a licensed healthcare provider. This bill would reclassify the medication to allow direct consumer purchase.
Ivermectin's regulatory status has become politically contentious due to its promotion as a COVID-19 treatment despite limited clinical evidence supporting that use. The bill raises questions about medication safety, consumer access, appropriate use, and the role of professional medical judgment in drug dispensation. Virginia's decision could influence other states' policies and set precedent for how states handle medications with disputed off-label uses.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.